Jiyang Yu

Jiyang Yu

Auto-generated profile, based on publicly available information

Jiyang Yu

Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2023 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
WSWei Su
Wei Su
JSJordy Saravia
Jordy Saravia
IRIsabel Risch
Isabel Risch
SRSherri Rankin
Sherri Rankin
CGCliff Guy
Cliff Guy
HCHongbo Chi
Hongbo Chi

30 May 2018 in Nature
Verified
Journal Article
Closed access
PDF file
XDXingrong Du
Xingrong Du
JWJing Wen
Jing Wen
YWYanyan Wang
Yanyan Wang
PKPeer W. F. Karmaus
Peer W. F. Karmaus
AKAlireza Khatamian
Alireza Khatamian
HCHongbo Chi
Hongbo Chi

21 January 2021 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
YGYoshihiro Gocho
Yoshihiro Gocho
JLJingjing Liu
Jingjing Liu
JHJianzhong Hu
Jianzhong Hu
WYWentao Yang
Wentao Yang
NDNeekesh V. Dharia
Neekesh V. Dharia
JYJun Yang
Jun Yang

7 July 2021 in Nature
Verified
Journal Article
Closed access
PDF file
GFGuotong Fu
Guotong Fu
CGClifford S. Guy
Clifford S. Guy
NCNicole M. Chapman
Nicole M. Chapman
GPGustavo Palacios
Gustavo Palacios
JWJun Wei
Jun Wei
HCHongbo Chi
Hongbo Chi

18 November 2021 in Nature
Verified
Journal Article
Closed access
PDF file
LLLingyun Long
Lingyun Long
JWJun Wei
Jun Wei
SLSeon Ah Lim
Seon Ah Lim
JRJana L. Raynor
Jana L. Raynor
HSHao Shi
Hao Shi
HCHongbo Chi
Hongbo Chi

11 October 2024 in Science
Verified
Journal Article
Closed access
TKTae Gun Kang
Tae Gun Kang
XLXin Lan
Xin Lan
TMTian Mi
Tian Mi
HCHongfeng Chen
Hongfeng Chen
SAShanta Alli
Shanta Alli
CZCaitlin C. Zebley
Caitlin C. Zebley
Epigenetic reinforcement of T cell exhaustion is known to be a major barrier limiting T cell responses during immunotherapy. However, the core epigenetic regulators restricting antitumor immunity during prolonged antigen exposure are not clear. We investigated three commonly mutated epigenetic regulators that promote clonal hematopoiesis to determine whether they affect T cell stemness and response to checkpoint blockade immunotherapy. CD8 T cells lacking Dnmt3a, Tet2, or Asxl1 preserved a progenitor-exhausted (Tpex) population for more than 1 year during chronic antigen exposure without undergoing malignant transformation. Asxl1 controlled the self-renewal capacity of T cells and reduced CD8 T cell differentiation through H2AK119 ubiquitination and epigenetic modification of the polycomb group–repressive deubiquitinase pathway. Asxl1-deficient T cells synergized with anti–PD-L1 immunotherapy to improve tumor control in experimental models and conferred a survival advantage to mutated T cells from treated patients.